Metoprolol spironolactone treatment of dilated cardiomyopathy and heart failure observation.docVIP

Metoprolol spironolactone treatment of dilated cardiomyopathy and heart failure observation.doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Metoprolol spironolactone treatment of dilated cardiomyopathy and heart failure observation

 PAGE \* MERGEFORMAT 9 Metoprolol spironolactone treatment of dilated cardiomyopathy and heart failure observation [Abstract] Objective To observe metoprolol spironolactone dilated cardiomyopathy with chronic heart failure patients. Methods 60 patients with dilated cardiomyopathy and chronic heart failure patients were randomly divided into two groups, control group of 30 patients, to diuretics, digitalis, angiotensin converting enzyme inhibitor (ACEI) and nitrate preparations conventional treatment, 30 cases observed in the control group based on the use of metoprolol, each time by a small dose of 6.25 mg, 2 times / d started 1 week dose was doubled, reaching 50 ~ 100 mg / d, while adding spironolactone 20 mg, 2 times / d, more than 6 months long-term use, so that resting heart rate of not less than 55 times / min, systolic blood pressure gt; = 90 mmHg. respectively, before treatment and 6 months underwent color Doppler cardiac patients were left ventricular fractional shortening (FS), left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVDD) , left ventricular end systolic diameter (LVESD), heart rate (HR), cardiac effects were observed. The results observed total effective rate was 93.3% in the control group, the total effective rate was 60.0%, total effective rate between the two groups was statistically significance (P lt;0.01). after treatment group, FS, LVDD, LVESD, and HR compared with control group there was significant difference (P lt;0.05 or 0.01), the two LVEF was no significant difference (Pgt; 0.05). Observation group heart rate, improve the FS, LVESD decreased LVDD and superior to the control group. Conclusion metoprolol spironolactone treatment can significantly improve heart failure patients with dilated cardiomyopathy and cardiac function and attenuates myocardial remodeling. [Keywords:] metoprolol; heart disease; myocardial remodeling; heart function With better understanding of the pathogenesis of he

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档